Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

The Cynomolgus Macaque Natural History Model of Pneumonic Tularemia for Predicting Clinical Efficacy Under the Animal Rule.

Guina T, Lanning LL, Omland KS, Williams MS, Wolfraim LA, Heyse SP, Houchens CR, Sanz P, Hewitt JA.

Front Cell Infect Microbiol. 2018 Apr 4;8:99. doi: 10.3389/fcimb.2018.00099. eCollection 2018.

2.

Developing Deep Learning Applications for Life Science and Pharma Industry.

Siegismund D, Tolkachev V, Heyse S, Sick B, Duerr O, Steigele S.

Drug Res (Stuttg). 2018 Jun;68(6):305-310. doi: 10.1055/s-0043-124761. Epub 2018 Jan 16.

PMID:
29341027
3.

Unified Software Solution for Efficient SPR Data Analysis in Drug Research.

Dahl G, Steigele S, Hillertz P, Tigerström A, Egnéus A, Mehrle A, Ginkel M, Edfeldt F, Holdgate G, O'Connell N, Kappler B, Brodte A, Rawlins PB, Davies G, Westberg EL, Folmer RH, Heyse S.

SLAS Discov. 2017 Feb;22(2):203-209. doi: 10.1177/1087057116675316. Epub 2016 Oct 28.

4.

Bacteriophages safely reduce Salmonella contamination in pet food and raw pet food ingredients.

Soffer N, Abuladze T, Woolston J, Li M, Hanna LF, Heyse S, Charbonneau D, Sulakvelidze A.

Bacteriophage. 2016 Aug 5;6(3):e1220347. eCollection 2016 Jul-Sep.

5.

RNAi Trigger Delivery into Anopheles gambiae Pupae.

Regna K, Harrison RM, Heyse SA, Chiles TC, Michel K, Muskavitch MA.

J Vis Exp. 2016 Mar 8;(109). doi: 10.3791/53738.

6.

Bacteriophage cocktail for biocontrol of Salmonella in dried pet food.

Heyse S, Hanna LF, Woolston J, Sulakvelidze A, Charbonneau D.

J Food Prot. 2015 Jan;78(1):97-103. doi: 10.4315/0362-028X.JFP-14-041.

PMID:
25581183
7.

Tetrahymena Pot2 is a developmentally regulated paralog of Pot1 that localizes to chromosome breakage sites but not to telomeres.

Cranert S, Heyse S, Linger BR, Lescasse R, Price C.

Eukaryot Cell. 2014 Dec;13(12):1519-29. doi: 10.1128/EC.00204-14. Epub 2014 Oct 10.

8.

Glucose-dependent de novo lipogenesis in B lymphocytes: a requirement for atp-citrate lyase in lipopolysaccharide-induced differentiation.

Dufort FJ, Gumina MR, Ta NL, Tao Y, Heyse SA, Scott DA, Richardson AD, Seyfried TN, Chiles TC.

J Biol Chem. 2014 Mar 7;289(10):7011-24. doi: 10.1074/jbc.M114.551051. Epub 2014 Jan 27.

9.

Bacteriophages lytic for Salmonella rapidly reduce Salmonella contamination on glass and stainless steel surfaces.

Woolston J, Parks AR, Abuladze T, Anderson B, Li M, Carter C, Hanna LF, Heyse S, Charbonneau D, Sulakvelidze A.

Bacteriophage. 2013 Jul 1;3(3):e25697. Epub 2013 Jul 26.

10.

Current trends in high-throughput screening.

Sterling J, Bojanic D, Eglen RM, Heyse S, Strulovici B.

Assay Drug Dev Technol. 2008 Aug;6(4):491-504. doi: 10.1089/adt.2008.9989. No abstract available.

PMID:
18795872
11.

Robust hit identification by quality assurance and multivariate data analysis of a high-content, cell-based assay.

Dürr O, Duval F, Nichols A, Lang P, Brodte A, Heyse S, Besson D.

J Biomol Screen. 2007 Dec;12(8):1042-9.

PMID:
18087069
12.

From targets to leads: the importance of advanced data analysis for decision support in drug discovery.

Fischer HP, Heyse S.

Curr Opin Drug Discov Devel. 2005 May;8(3):334-46. Review.

PMID:
15892249
13.

Spondyloarthropathy in the community: differences in severity and disease expression in Alaskan Eskimo men and women.

Boyer GS, Templin DW, Bowler A, Lawrence RC, Heyse SP, Everett DF, Cornoni-Huntley JC, Goring WP.

J Rheumatol. 2000 Jan;27(1):170-6.

PMID:
10648035
14.

Micropatterned immobilization of a G protein-coupled receptor and direct detection of G protein activation.

Bieri C, Ernst OP, Heyse S, Hofmann KP, Vogel H.

Nat Biotechnol. 1999 Nov;17(11):1105-8.

PMID:
10545918
15.

Global statistical tests for comparing multiple outcomes in rheumatoid arthritis trials. MIRA Trial Group.

Tilley BC, Pillemer SR, Heyse SP, Li S, Clegg DO, Alarcón GS.

Arthritis Rheum. 1999 Sep;42(9):1879-88.

16.

International variation in the incidence of hip fractures: cross-national project on osteoporosis for the World Health Organization Program for Research on Aging.

Schwartz AV, Kelsey JL, Maggi S, Tuttleman M, Ho SC, Jónsson PV, Poór G, Sisson de Castro JA, Xu L, Matkin CC, Nelson LM, Heyse SP.

Osteoporos Int. 1999;9(3):242-53.

PMID:
10450414
17.

Spondyloarthropathy in the community: clinical syndromes and disease manifestations in Alaskan Eskimo populations.

Boyer GS, Templin DW, Bowler A, Lawrence RC, Heyse SP, Everett DF, Cornoni-Huntley JC.

J Rheumatol. 1999 Jul;26(7):1537-44.

PMID:
10405942
18.

Updated data on proximal femur bone mineral levels of US adults.

Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, Johnston CC Jr, Lindsay R.

Osteoporos Int. 1998;8(5):468-89.

PMID:
9850356
19.

Emerging techniques for investigating molecular interactions at lipid membranes.

Heyse S, Stora T, Schmid E, Lakey JH, Vogel H.

Biochim Biophys Acta. 1998 Nov 10;1376(3):319-38. Review. No abstract available.

PMID:
9804980
20.

Epidemiology of osteoporosis in women in southern Italy.

del Puente A, Heyse SP, Mandes MG, Mantova D, Carpinelli A, Nutile G, Oriente P.

Aging (Milano). 1998 Feb;10(1):53-8.

PMID:
9589752
21.

Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States.

Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, Heyse SP, Hirsch R, Hochberg MC, Hunder GG, Liang MH, Pillemer SR, Steen VD, Wolfe F.

Arthritis Rheum. 1998 May;41(5):778-99.

PMID:
9588729
22.
23.

Prevalence of low femoral bone density in older U.S. adults from NHANES III.

Looker AC, Orwoll ES, Johnston CC Jr, Lindsay RL, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP.

J Bone Miner Res. 1997 Nov;12(11):1761-8.

24.

A comparison of patients with spondyloarthropathy seen in specialty clinics with those identified in a communitywide epidemiologic study. Has the classic case misled us?

Boyer GS, Templin DW, Bowler A, Lawrence RC, Everett DF, Heyse SP, Cornoni-Huntley J, Goring WP.

Arch Intern Med. 1997 Oct 13;157(18):2111-7.

PMID:
9382668
25.

A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. Minocycline in Rheumatoid Arthritis Trial Group.

Tuttleman M, Pillemer SR, Tilley BC, Fowler SE, Buckley LM, Alarcón GS, Trentham DE, Neuner R, Clegg DO, Leisen JC, Heyse SP.

J Rheumatol. 1997 Oct;24(10):1910-5.

PMID:
9330931
26.

Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial.

Bluhm GB, Sharp JT, Tilley BC, Alarcon GS, Cooper SM, Pillemer SR, Clegg DO, Heyse SP, Trentham DE, Neuner R, Kaplan DA, Leisen JC, Buckley L, Duncan H, Tuttleman M, Li S, Fowler SE.

J Rheumatol. 1997 Jul;24(7):1295-302.

PMID:
9228128
27.

Meaningful improvement criteria sets in a rheumatoid arthritis clinical trial. MIRA Trial Group. Minocycline in Rheumatoid Arthritis.

Pillemer SR, Fowler SE, Tilley BC, Alarcón GS, Heyse SP, Trentham DE, Neuner R, Clegg DO, Leisen JC, Cooper SM, Duncan H, Tuttleman M.

Arthritis Rheum. 1997 Mar;40(3):419-25.

PMID:
9082927
28.

Class I HLA antigens in spondyloarthropathy: observations in Alaskan Eskimo patients and controls.

Boyer GS, Templin DW, Bowler A, Lawrence RC, Heyse SP, Everett DF, Cornoni-Huntley JC, Goring WP.

J Rheumatol. 1997 Mar;24(3):500-6.

PMID:
9058656
29.

Spondylarthropathic diseases in indigenous circumpolar populations of Russia and Alaska.

Benevolenskaya LI, Boyer GS, Erdesz S, Templin DW, Alexeeva LI, Lawrence RC, Heyse SP, Krylov MY, Mylov NM, Cornoni-Huntley JC, Everett DF, Goring WP, Bowler A.

Rev Rhum Engl Ed. 1996 Dec;63(11):815-22.

PMID:
9010969
30.

HLA-DRB1 genes and disease severity in rheumatoid arthritis. The MIRA Trial Group. Minocycline in Rheumatoid Arthritis.

Reveille JD, Alarcón GS, Fowler SE, Pillemer SR, Neuner R, Clegg DO, Mikhail IS, Trentham DE, Leisen JC, Bluhm G, Cooper SM, Duncan H, Tuttleman M, Heyse SP, Sharp JT, Tilley B.

Arthritis Rheum. 1996 Nov;39(11):1802-7.

PMID:
8912501
31.

Spondyloarthropathies in circumpolar populations: II. Characterization of the populations.

Boyer GS, Benevolenskaya LI, Templin DW, Erdesz S, Alexeeva LI, Lawrence RC, Heyse SP, Krylov MYu, Mylov NM, Cornoni-Huntley JC, Everett DF, Goring WP, Bowler A.

Arctic Med Res. 1996 Oct;55(4):195-203.

PMID:
9115546
32.

Spondyloarthropathies in circumpolar populations: I. Design and methods of United States and Russian studies.

Lawrence RC, Everett DF, Benevolenskaya LI, Boyer GS, Erdesz S, Templin DW, Alexeeva LI, Lanier AP, Krylov MYu, Cornoni-Huntley JC, Mylov NM, Heyse S.

Arctic Med Res. 1996 Oct;55(4):187-94.

PMID:
9115545
33.

Antigen binding properties of purified immunoglobulin A and reconstituted secretory immunoglobulin A antibodies.

Lüllau E, Heyse S, Vogel H, Marison I, von Stockar U, Kraehenbuhl JP, Corthésy B.

J Biol Chem. 1996 Jul 5;271(27):16300-9.

34.

Arthritis and other rheumatic conditions: who is affected now, who will be affected later? National Arthritis Data Workgroup.

Helmick CG, Lawrence RC, Pollard RA, Lloyd E, Heyse SP.

Arthritis Care Res. 1995 Dec;8(4):203-11.

PMID:
8605258
35.
36.

Discrepancies between patient recall and the medical record. Potential impact on diagnosis and clinical assessment of chronic disease.

Boyer GS, Templin DW, Goring WP, Cornoni-Huntley JC, Everett DF, Lawrence RC, Heyse SP, Bowler A.

Arch Intern Med. 1995 Sep 25;155(17):1868-72.

PMID:
7677553
37.

Prevalence of low femoral bone density in older U.S. women from NHANES III.

Looker AC, Johnston CC Jr, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, Lindsay RL.

J Bone Miner Res. 1995 May;10(5):796-802.

PMID:
7639115
38.

Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.

Tilley BC, Alarcón GS, Heyse SP, Trentham DE, Neuner R, Kaplan DA, Clegg DO, Leisen JC, Buckley L, Cooper SM, Duncan H, Pillemer SR, Tuttleman M, Fowler SE.

Ann Intern Med. 1995 Jan 15;122(2):81-9.

PMID:
7993000
39.

Proximal femur bone mineral levels of US adults.

Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, Johnston CC Jr, Lindsay RL.

Osteoporos Int. 1995;5(5):389-409.

PMID:
8800790
40.

Prevalence of spondyloarthropathies in Alaskan Eskimos.

Boyer GS, Templin DW, Cornoni-Huntley JC, Everett DF, Lawrence RC, Heyse SF, Miller MM, Goring WP.

J Rheumatol. 1994 Dec;21(12):2292-7.

PMID:
7699631
41.

Partial reactions of the Na,K-ATPase: determination of rate constants.

Heyse S, Wuddel I, Apell HJ, Stürmer W.

J Gen Physiol. 1994 Aug;104(2):197-240.

42.
43.

Incidence of hip fractures in the elderly: a cross-national analysis.

Maggi S, Kelsey JL, Litvak J, Heyse SP.

Osteoporos Int. 1991 Sep;1(4):232-41. Review.

PMID:
1790410
44.

Design and conduct of collaborative international epidemiologic studies of rheumatic diseases.

Heyse SP.

Rheum Dis Clin North Am. 1990 Aug;16(3):763-72. Review.

PMID:
2217967
45.
46.

Epidemiology of osteoporosis: a study of fracture mortality in Italy.

Heyse SP, Sartori L, Crepaldi G.

Calcif Tissue Int. 1990 May;46(5):289-93. Review. No abstract available.

PMID:
2110851
47.

Technology assessment in biomedical research: magnetic resonance imaging as a case in point.

Burton BT, Heyse SP.

J Nucl Med Allied Sci. 1985 Oct-Dec;29(4):331-5. No abstract available.

PMID:
3835248
48.

Supplemental Content

Support Center